Interventional Management of Stroke (IMS) II Study


Phase 2 Results

Summary of Purpose

The purpose of this study is to examine the effects of delivering intra-arterial recombinant tissue plasminogen activator (rt-PA) and ultrasound to the site of the blood clot blocking blood flow to the brain of stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 July 2012.

1 Jan 2003 24 Oct 2005 1 May 2006 1 May 2007 1 Jul 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


  • Judith Spilker RN, Clinical Coordinator IMS Study.